يعرض 51 - 60 نتائج من 119 نتيجة بحث عن '"METJIAN, Ara"', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 51
    دورية
    African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

    المؤلفون: Liu, Angela, Mazepa, Marshall, Davis, Elizabeth, Johnson, Andrew, Antun, Ana G, Farland, Andrew M., Woods, Ryan R, Metjian, Ara, Bagby, Kristin, Park, Yara, Raval, Jay S, de Ridder, Gustaaf, Gibson, Briana, Kasthuri, Raj S., Liles, Darla K, Eubanks, Susan, Akwaa, Frank, Baumann Kreuziger, Lisa, Sadler, J Evan, Sridharan, Meera, Go, Ronald S., Kohli, Rahil, Upreti, Harsh Vardhan, McCrae, Keith R, Lim, Ming Y., Zheng, X. Long, Kocher, Nicole K., Gangaraju, Radhika, Cataland, Spero, Chaturvedi, Shruti

    المصدر: Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p1066-1066, 1p

    النص الكامل

    أضف إلى المفضلة
  2. 52
    دورية
    Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

    المؤلفون: Cataland, Spero, Scully, Marie, Peyvandi, Flora, Knoebl, Paul, Kremer Hovinga, Johanna A., Coppo, Paul, Metjian, Ara, De La Rubia, Javier, Pavenski, Katerina, De Winter, Hilde, Callewaert, Filip

    المصدر: Blood; November 2019, Vol. 134 Issue: Supplement 1 p4908-4908, 1p

    النص الكامل

    أضف إلى المفضلة
  3. 53
    دورية
    Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity

    المؤلفون: Coppo, Paul, Cataland, Spero, Peyvandi, Flora, Knoebl, Paul, Scully, Marie, Kremer Hovinga, Johanna A., Metjian, Ara, De La Rubia, Javier, Pavenski, Katerina, De Winter, Hilde, de Passos Sousa, Rui, Callewaert, Filip

    المصدر: Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p2366-2366, 1p

    النص الكامل

    أضف إلى المفضلة
  4. 54
    دورية
    Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen

    المؤلفون: Pavenski, Katerina, Knoebl, Paul, Scully, Marie, Kremer Hovinga, Johanna A., Coppo, Paul, Peyvandi, Flora, Cataland, Spero, Metjian, Ara, De La Rubia, Javier, De Winter, Hilde, de Passos Sousa, Rui, Callewaert, Filip

    المصدر: Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p2365-2365, 1p

    النص الكامل

    أضف إلى المفضلة
  5. 55
    دورية أكاديمية
    rVWF: treatment finally reaches the modern age.

    المؤلفون: Metjian, Ara D.1

    المصدر: Blood. 10/22/2015, Vol. 126 Issue 17, p1975-1976. 2p.

    مصطلحات موضوعية: *VON Willebrand factor, *HEMORRHAGE treatment, *VON Willebrand disease treatment, *CLINICAL trials, *PHARMACOKINETICS

    النص الكامل

    أضف إلى المفضلة
  6. 56
    دورية
    Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

    المؤلفون: Peyvandi, Flora, Cataland, Spero R, Scully, Marie, Coppo, Paul, Knöbl, Paul, Kremer Hovinga, Johanna A., Metjian, Ara, De La Rubia, Javier, Pavenski, Katerina, Minkue, Jessica, Callewaert, Filip, De Winter, Hilde

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p373-373, 1p

    النص الكامل

    أضف إلى المفضلة
  7. 57
    دورية
    Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study

    المؤلفون: Cataland, Spero R, Scully, Marie, Peyvandi, Flora, Coppo, Paul, Knöbl, Paul, Kremer Hovinga, Johanna A., Metjian, Ara, De La Rubia, Javier, Pavenski, Katerina, Minkue, Jessica, Sousa, Rui Passos, Callewaert, Filip, De Winter, Hilde

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p1142-1142, 1p

    النص الكامل

    أضف إلى المفضلة
  8. 58
    دورية
    Safety of Caplacizumab for the Treatment of Patients with Acquired Thrombotic Thrombocytopenic Purpura - Results Normalized to Time of Exposure in a Double-Blind, Placebo-Controlled, Phase 3 Hercules Study

    المؤلفون: Kremer Hovinga, Johanna A., Scully, Marie, Cataland, Spero R, Peyvandi, Flora, Coppo, Paul, Knöbl, Paul, De La Rubia, Javier, Pavenski, Katerina, Minkue, Jessica, Sousa, Rui Passos, Callewaert, Filip, De Winter, Hilde, Metjian, Ara

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p3744-3744, 1p

    النص الكامل

    أضف إلى المفضلة
  9. 59
    دورية
    Integrated Safety Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

    المؤلفون: Knöbl, Paul, Scully, Marie, Cataland, Spero R, Peyvandi, Flora, Coppo, Paul, Kremer Hovinga, Johanna A., Metjian, Ara, De La Rubia, Javier, Pavenski, Katerina, Minkue, Jessica, Callewaert, Filip, De Winter, Hilde

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p3739-3739, 1p

    النص الكامل

    أضف إلى المفضلة
  10. 60
    دورية
    Efficacy of Adjuvant Low Dose Rituximab and Plasma Exchange for Acquired TTP with Severe ADAMTS13 Deficiency — Results of the ART Study

    المؤلفون: Sadler, J. Evan, Muia, Joshua, Dolatshahi, Leili, Westfield, Lisa A., Nieters, Patricia, Rodrigues, Anita, Antun, Ana G., Metjian, Ara, Zwicker, Jeffrey I.

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p374-374, 1p

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث